Sam Chun Dang Pharm. Co., Ltd (KOSDAQ:000250)
179,900
-1,000 (-0.55%)
Feb 21, 2025, 3:30 PM KST
Sam Chun Dang Pharm. Revenue
Sam Chun Dang Pharm. had revenue of 52.38B KRW in the quarter ending September 30, 2024, with 8.13% growth. This brings the company's revenue in the last twelve months to 208.22B, up 12.75% year-over-year. In the year 2023, Sam Chun Dang Pharm. had annual revenue of 192.67B with 8.65% growth.
Revenue (ttm)
208.22B
Revenue Growth
+12.75%
P/S Ratio
19.94
Revenue / Employee
509.10M
Employees
409
Market Cap
4,184.02B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 192.67B | 15.33B | 8.65% |
Dec 31, 2022 | 177.34B | 10.06B | 6.01% |
Dec 31, 2021 | 167.27B | 412.57M | 0.25% |
Dec 31, 2020 | 166.86B | -19.74B | -10.58% |
Dec 31, 2019 | 186.60B | 26.64B | 16.66% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 300.87T |
SK hynix | 57.73T |
LG Energy Solution | 25.62T |
Samsung Biologics | 4,364.39B |
Hyundai Motor Company | 170.28T |
Celltrion | 2,876.25B |
Kia Corporation | 104.63T |
NAVER | 10.39T |